Expression of cysteine proteinases and cystatins in parasites and use of cysteine proteinase inhibitors in parasitic diseases. Part I: Helminths

被引:1
作者
Abaza, Sherif M. [1 ]
机构
[1] Suez Canal Univ, Fac Med, Parasitol Dept, Ismailia, Egypt
关键词
Apoptosis; caspases; cathepsin; cystatins; cysteine proteinase; cysteine proteinase inhibitor; drug target; MEROPS; vaccine;
D O I
10.21608/puj.2017.1730.1002
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Cysteine proteinase (CP) is a new era as well as interesting topic in several publications during the last two decades. CPs enable several different biological activities in parasite biology and pathogenesis such as digestion of host proteins for nutrition, invasion through cellular and tissue barriers, processing secondary protein modifications for parasite survival as well as manipulation of the host immune system (iininunomodulation). In this regard, CPs, like heat shock proteins, are suggested to be virulence factors and serodiagnostic markers. Therefore, CPs data are utilized as drug targets or vaccine candidates through use of their inhibitors as well as in diagnosis of several parasitic diseases. MEROPS is an on-line database for classification, characterization and structural properties of all identified proteinases and their inhibitors. Parasites express not only proteolytic enzymes for their survival and long persistence, but also inhibitors; cystatins, serpins and aspins to inhibit cysteine, serine and aspartic proteinases, respectively, both of the host and their own. On the other hand, CPs inhibitors (CPIs) are either general, inhibiting members of all classes of proteinases, or specific; inhibiting only one class of proteinases. However, a new classification was adopted in 2007, according to their structure; either with low molecular weight peptidomimetic inhibitors or those composed of one or more peptide chains. In spite of that, the majority of research studies used the old classification, general and specific CPIs. The main objective of the this review is to present updated data for all identified CPs and CYSs expressed in helminths and use of their CPIs as chemotherapeutic drug targets or as protective vaccine candidates. The secondary objective is to simplify, as possible, new approaches for drug and vaccine development as well as accurate diagnostic methods in parasitological researches utilizing the terrible evolution in bioinformatics and technology.
引用
收藏
页码:7 / 31
页数:25
相关论文
共 235 条
  • [1] Abaza SM, 2013, PUJ, V6, P99
  • [2] Abdul-Fattah Mohiedden M., 2000, Journal of the Egyptian Society of Parasitology, V30, P621
  • [3] Schistosomiasis mansoni: Novel chemotherapy using a cysteine protease inhibitor
    Abdulla, Maha-Hamadien
    Lim, Kee-Chong
    Sajid, Mohammed
    McKerrow, James H.
    Caffrey, Conor R.
    [J]. PLOS MEDICINE, 2007, 4 (01): : 130 - 138
  • [4] ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685
  • [5] Comparative molecular analysis of two asparaginyl endopeptidases and encoding genes from Fasciola gigantica
    Adisakwattana, Poom
    Viyanant, Vithoon
    Chaicumpa, Wanpen
    Vichasri-Grams, Suksiri
    Hofmann, Annemarie
    Korge, Guenter
    Sobhon, Prasert
    Grams, Rudi
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2007, 156 (02) : 102 - 116
  • [6] Effect of a cysteine protease inhibitor on Fasciola hepatica (liver fluke) fecundity, egg viability, parasite burden, and size in experimentally infected sheep
    Alcala-Canto, Yazmin
    Ibarra-Velarde, Froylan
    Sumano-Lopez, Hector
    Gracia-Mora, Jesus
    Alberti-Navarro, Aldo
    [J]. PARASITOLOGY RESEARCH, 2007, 100 (03) : 461 - 465
  • [7] HDAC inhibitors in parasitic diseases
    Andrews, Katherine T.
    Haque, Ashraful
    Jones, Malcolm K.
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (01) : 66 - 77
  • [8] Diagnosis of Fasciola gigantica infection using a monoclonal antibody-based sandwich ELISA for detection of circulating cathepsin B3 protease
    Anuracpreeda, Panat
    Chawengkirtikul, Runglawan
    Tinikul, Yotsawan
    Poljaroen, Jaruwan
    Chotwiwatthanakun, Charoonroj
    Sobhon, Prasert
    [J]. ACTA TROPICA, 2013, 127 (01) : 38 - 45
  • [9] Fasciola gigantica: Production and characterization of a monoclonal antibody against recombinant cathepsin B3
    Anuracpreeda, Panat
    Songkoomkrong, Sineenart
    Sethadavit, Manussabhorn
    Chotwiwatthanakun, Charoonroj
    Tinikul, Yotsawan
    Sobhon, Prasert
    [J]. EXPERIMENTAL PARASITOLOGY, 2011, 127 (02) : 340 - 345
  • [10] Vaccination with recombinant Brugia malayi cystatin proteins alters worm migration, homing and final niche selection following a subcutaneous challenge of Mongolian gerbils (Meriones unguiculatus) with B. malayi infective larvae
    Arumugam, Sridhar
    Zhan, Bin
    Abraham, David
    Ward, Danielle
    Lustigman, Sara
    Klei, Thomas R.
    [J]. PARASITES & VECTORS, 2014, 7